Position in ABBV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,043,551
+$117,697 QoQ
Shares Held
4,147
-2.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#2,494
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Newman Dignan & Sheerar, Inc. holds $16,082,023 across 8 Drug Manufacturers - General names. ABBV ranks #5 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,236 | $5,393,306 | |
| 2 | MRK |
Merck & Co., Inc.
|
28,738 | $3,692,833 | |
| 3 | AMGN |
Amgen Inc
|
7,582 | $2,745,593 | |
| 4 | LLY |
ELI LILLY & Co
|
1,043 | $1,251,005 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
4,147 | $1,043,551 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
17,344 | $999,361 | |
| 7 | NVS |
Novartis AG
|
3,499 | $548,363 | |
| 8 | PFE |
Pfizer Inc
|
16,944 | $408,011 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,043,551 | 4,147 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $925,854 | 4,257 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $977,937 | 4,280 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $977,098 | 4,220 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $749,904 | 4,040 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $845,413 | 4,035 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $690,364 | 3,885 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $776,096 | 3,930 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $670,643 | 3,910 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $715,653 | 3,930 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $615,075 | 3,969 | Shares | Sole | 2024-02-09 | |
| 2023-06-30 | $541,614 | 4,020 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $683,697 | 4,290 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $701,387 | 4,340 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $577,237 | 4,301 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $645,109 | 4,212 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $690,912 | 4,262 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $526,299 | 3,887 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $421,448 | 3,907 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $440,084 | 3,907 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $426,062 | 3,937 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $421,849 | 3,937 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $371,118 | 4,237 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $356,491 | 3,631 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $240,074 | 3,151 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||